All stock lists
Anheuser-Busch Inbev SA Sponsor (New York Stock Exchange:BUD)
BE · Delayed Price · Currency is USD
Consumer Defensive · Beverages - Alcoholic
80.98-0.39 (-0.48%)
Market cap
$161B
Insider Score
Health Score
Analyst consensus
Listed since
Jul 1, 2009
Website
Insider Score
––Not scored
BUD Insider Score
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
BUD analyst forecast
BUD analyst consensus
Moderate Buy2 ratings
Buy 1 Hold 1 Sell 0
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
BUD 12-month price target
No published price targets in the last 12 months.
BUD ratings mix, last 12 months
Buy Hold Sell
Best analysts covering BUD
- Evercore ISI Group100%success rate · +14.7% avg return · 1 call
- Morgan Stanley67%success rate · +6.1% avg return · 3 calls
- JP Morgan0%success rate · -12.3% avg return · 1 call
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
BUD analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| — | TD Cowen | Hold | — | — | Reiterated | 2026-10-13 |
| — | Wells Fargo | Overweight | — | — | Reiterated | 2026-10-05 |
| — | Wells Fargo | Overweight | — | — | Reiterated | 2026-07-31 |
| — | Barclays | Equal Weight | — | — | Downgraded | 2026-07-27 |
| — | Morgan Stanley | Overweight | — | — | Reiterated | 2026-07-02 |
| — | TD Cowen | Hold | — | — | Reiterated | 2026-06-26 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2026-05-07 |
| — | Wells Fargo | Overweight | — | — | Reiterated | 2026-05-06 |
| — | Evercore ISI Group | Outperform | — | — | Reiterated | 2026-02-13 |
| — | Wells Fargo | Overweight | — | — | Reiterated | 2026-02-13 |
| — | Wells Fargo | Overweight | — | — | Reiterated | 2026-02-09 |
| — | Goldman Sachs | Buy | — | — | Upgraded | 2025-05-12 |
| — | TD Cowen | Hold | — | — | Reiterated | 2025-01-08 |
| — | TD Cowen | Hold | — | — | Downgraded | 2024-10-08 |
| — | Citigroup | Buy | — | — | Upgraded | 2024-10-01 |
| — | Morgan Stanley | Overweight | — | — | Reiterated | 2024-09-10 |
| — | Morgan Stanley | Overweight | — | — | Reiterated | 2024-07-02 |
| — | TD Cowen | Outperform | — | — | Reiterated | 2024-03-05 |
| — | Exane BNP Paribas | Neutral | — | — | Downgraded | 2024-01-12 |
| — | Jefferies | Buy | — | — | Upgraded | 2024-01-10 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2023-11-29 |
| — | B of A Securities | Buy | — | — | Upgraded | 2023-09-29 |
| — | Morgan Stanley | Overweight | — | — | Upgraded | 2023-07-20 |
| — | Deutsche Bank | Buy | — | — | Upgraded | 2023-06-22 |
| — | Evercore ISI Group | Outperform | — | — | Reiterated | 2023-06-08 |
| — | Redburn Partners | Buy | — | — | Upgraded | 2021-11-19 |
| — | Argus Research | Hold | — | — | Downgraded | 2021-09-30 |
| — | JP Morgan | Underweight | — | — | Downgraded | 2021-09-02 |
| — | Argus Research | Buy | — | — | Reiterated | 2021-06-18 |
| — | Jefferies | Buy | — | — | Upgraded | 2020-10-07 |
| — | Evercore ISI Group | Outperform | — | — | Upgraded | 2020-07-30 |
| — | CFRA | Hold | — | — | Reiterated | 2020-05-26 |
| — | JP Morgan | Neutral | — | — | Upgraded | 2020-05-20 |
| — | RBC Capital | Outperform | — | — | Upgraded | 2020-03-12 |
| — | Credit Suisse | Neutral | — | — | Downgraded | 2020-03-09 |
| — | B of A Securities | Neutral | — | — | Downgraded | 2020-03-03 |
| — | Bryan Garnier | Neutral | — | — | Downgraded | 2020-02-28 |
| — | JP Morgan | Underweight | — | — | Downgraded | 2020-02-20 |
| — | Redburn Partners | Neutral | — | — | Upgraded | 2019-11-18 |
| — | Redburn | Neutral | — | — | Upgraded | 2019-11-18 |
| — | JP Morgan | Neutral | — | — | Reiterated | 2019-11-07 |
| — | Barclays | Underweight | — | — | Downgraded | 2019-08-27 |
| — | UBS | Neutral | — | — | Downgraded | 2019-08-06 |
| — | B of A Securities | Buy | — | — | Upgraded | 2019-07-29 |
| — | Bank of America | Buy | — | — | Upgraded | 2019-07-29 |
| — | Argus Research | Buy | — | — | Upgraded | 2019-05-30 |
| — | RBC Capital | Sector Perform | — | — | Downgraded | 2019-03-07 |
| — | Macquarie | Neutral | — | — | Reiterated | 2019-03-01 |
| — | RBC Capital | Top Pick | — | — | Upgraded | 2019-01-22 |
| — | Jefferies | Underperform | — | — | Downgraded | 2019-01-16 |
| — | Argus | Hold | — | — | Downgraded | 2018-11-12 |
| — | Argus Research | Hold | — | — | Downgraded | 2018-11-12 |
| — | RBC Capital | Outperform | — | — | Upgraded | 2018-10-29 |
| — | Jefferies | Hold | — | — | Downgraded | 2018-10-01 |
| — | HSBC | Buy | — | — | Upgraded | 2018-06-04 |
| — | Bank of America | Underperform | — | — | Downgraded | 2018-04-26 |
| — | B of A Securities | Underperform | — | — | Downgraded | 2018-04-26 |
| — | JP Morgan | Underweight | — | — | Reiterated | 2018-04-11 |
| — | Bernstein | Outperform | — | — | Upgraded | 2018-03-12 |
| — | JP Morgan | Underweight | — | — | Reiterated | 2018-03-05 |
BUD earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2025-05-08 | 0.77 | 0.81 | $15.54B | $29.89B |
| 2025-10-30 | 0.97 | 0.99 | $15.60B | $30.01B |
| 2026-05-05 | 0.90 | 0.97 | $14.69B | $30.61B |
| 2026-07-30 | 1.09 | 1.21 | $16.28B | $31.93B |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.